PDS Biotechnology Corporation (PDSB)
PDS Biotech Announces Final Topline Survival Data from VERSATILE-002 Phase 2 Trial in Head and Neck Cancer
PDS Biotech Announces Final Topline Survival Data from VERSATILE-002 Phase 2 Trial in Head and Neck Cancer
CoyaTherapeutics - Coya Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Biofrontera Notification (BFRI)
Biofrontera Inc. Announces Last-Patient-Out in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris
NASDAQ: SPPI DEADLINE REMINDER: Berger Montague Reminds Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Investors of Important Class Action Lawsuit Deadline
Hyperfine, Inc. to Participate in Upcoming Investor Conferences
New Form 8-K - CareCloud, Inc. Filed: 2025-08-25 AccNo: 0001493152-25-012294 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item …
Inovio - INOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Precigen to Participate in Upcoming Virtual Fireside Chats Hosted by Cantor and H.C. Wainwright
24/7 Market News: LIXTE Targets Large, Unmet Oncology Markets
24/7 Market News: LIXTE Targets Large, Unmet Oncology Markets
Precigen to Participate in Upcoming Virtual Fireside Chats Hosted by Cantor and H.C. Wainwright
Catalyst Pharmaceuticals Announces Settlement ofFIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals
Bionano to Present at the H.C. Wainwright 27th Annual Global Investment Conference